<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Neuromuscular Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Neuromuscular Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Нервно-мышечные болезни</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-8721</issn><issn publication-format="electronic">2413-0443</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">631</article-id><article-id pub-id-type="doi">10.17650/2222-8721-2024-14-4-12-20</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Intracortical inhibiton assessment using threshold tracking technique in amyotrophic lateral sclerosis</article-title><trans-title-group xml:lang="ru"><trans-title>Оценка внутрикоркового торможения с применением методики отслеживания порога при боковом амиотрофическом склерозе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0716-3737</contrib-id><name-alternatives><name xml:lang="en"><surname>Bakulin</surname><given-names>I. S.</given-names></name><name xml:lang="ru"><surname>Бакулин</surname><given-names>И. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> Ilya Sergeevich Bakulin </p><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> Илья Сергеевич Бакулин </p><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><email>bakulin@neurology.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8544-3107</contrib-id><name-alternatives><name xml:lang="en"><surname>Zabirova</surname><given-names>A. Kh.</given-names></name><name xml:lang="ru"><surname>Забирова</surname><given-names>А. Х.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1841-1177</contrib-id><name-alternatives><name xml:lang="en"><surname>Poydasheva</surname><given-names>A. G.</given-names></name><name xml:lang="ru"><surname>Пойдашева</surname><given-names>А. Г.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9951-9803</contrib-id><name-alternatives><name xml:lang="en"><surname>Sinitsyn</surname><given-names>D. O.</given-names></name><name xml:lang="ru"><surname>Синицын</surname><given-names>Д. О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9267-8315</contrib-id><name-alternatives><name xml:lang="en"><surname>Lagoda</surname><given-names>D. Yu.</given-names></name><name xml:lang="ru"><surname>Лагода</surname><given-names>Д. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-3653-2736</contrib-id><name-alternatives><name xml:lang="en"><surname>Nagieva</surname><given-names>A. R.</given-names></name><name xml:lang="ru"><surname>Нагиева</surname><given-names>А. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1072-9968</contrib-id><name-alternatives><name xml:lang="en"><surname>Zakharova</surname><given-names>M. N.</given-names></name><name xml:lang="ru"><surname>Захарова</surname><given-names>М. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3956-6362</contrib-id><name-alternatives><name xml:lang="en"><surname>Suponeva</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Супонева</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6338-0392</contrib-id><name-alternatives><name xml:lang="en"><surname>Piradov</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Пирадов</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p> 80 Volokolamskoe Shosse, Моscow 125367 </p></bio><bio xml:lang="ru"><p> 125367 Москва, Волоколамское шоссе, 80 </p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Neurology</institution></aff><aff><institution xml:lang="ru">ФГБНУ «Научный центр неврологии»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-12-26" publication-format="electronic"><day>26</day><month>12</month><year>2024</year></pub-date><volume>14</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>12</fpage><lpage>20</lpage><history><date date-type="received" iso-8601-date="2025-01-09"><day>09</day><month>01</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-01-09"><day>09</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bakulin I.S., Zabirova A.K., Poydasheva A.G., Sinitsyn D.O., Lagoda D.Y., Nagieva A.R., Zakharova M.N., Suponeva N.A., Piradov M.A.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Бакулин И.С., Забирова А.Х., Пойдашева А.Г., Синицын Д.О., Лагода Д.Ю., Нагиева А.Р., Захарова М.Н., Супонева Н.А., Пирадов М.А.</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bakulin I.S., Zabirova A.K., Poydasheva A.G., Sinitsyn D.O., Lagoda D.Y., Nagieva A.R., Zakharova M.N., Suponeva N.A., Piradov M.A.</copyright-holder><copyright-holder xml:lang="ru">Бакулин И.С., Забирова А.Х., Пойдашева А.Г., Синицын Д.О., Лагода Д.Ю., Нагиева А.Р., Захарова М.Н., Супонева Н.А., Пирадов М.А.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://nmb.abvpress.ru/jour/article/view/631">https://nmb.abvpress.ru/jour/article/view/631</self-uri><abstract xml:lang="en"><p><bold>Background</bold>. Assessment of short-interval intracortical inhibition (SICI) using paired-pulse transcranial magnetic stimulation (TMS) and the threshold tracking technique is a promising approach to develop biomarkers of motor cortex damage in amyotrophic lateral sclerosis (ALS). Both high sensitivity and specificity of this approach were shown previously; however, almost all studies in this field were conducted by one group of authors.</p><p><bold>Aim</bold>. The replication of data showing impairment of SICI assessed by threshold tracking technique in patients with ALS.</p><p><bold>Materials and methods.</bold> 18 patients with ALS and 13 healthy volunteers were included into the study. Functional state of the patients was assessed as well as disease duration, form, stage and progression rate. Following values were determined in all participants using TMS: 1) resting motor threshold (MT); 2) mean motor evoked potential (MEP) amplitude of 30 stimuli applied with an intensity of 120 % MT; 3) SICI assessed using an algorithm based on paralleled optimized threshold tracking with interstimulus interval (ISI) of 1.0 ms, 1.5 ms, 2.0 ms, 2.5 ms, 3.0 ms, 3.5 ms, 4.0 ms, 5.0 ms, 7.0 ms, as well as mean inhibition for values with ISI from 1.0 to 3.0 ms and from 1.0 to 7.0 ms.</p><p><bold>Results</bold>. No significant differences between groups were observed for MT and MEP amplitude. Significant decrease of SICI with ISI 1.0 and 2.0 ms as well as mean SICI from 1.0 and 3.0 ms was observed in ALS. No significant correlations of MT, MEP amplitude or SICI with clinical values were found.</p><p><bold>Conclusion</bold>. This replication study has shown the ability of paired-pulse TMS with threshold tracking technique to identify the impairment of intracortical inhibition in patients with ALS.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение</bold>. Оценка короткоинтервального внутрикоркового торможения (short-interval intracortical inhibition, SICI) c применением транскраниальной магнитной стимуляции (ТМС) парными стимулами и методики отслеживания порога – перспективный подход для разработки биомаркеров поражения моторной коры при боковом амиотрофическом склерозе (БАС). Ранее показаны высокая чувствительность и специфичность данной методики, однако почти все исследования в этой области были выполнены одной группой авторов.</p><p><bold>Цель исследования</bold> – репликация данных о нарушении SICI с использованием методики отслеживания порога у пациентов с БАС.</p><p><bold>Материалы и методы</bold>. В исследование были включены 18 пациентов с БАС и 13 здоровых добровольцев. У пациентов проводилась оценка функционального состояния, определялись продолжительность, форма, стадия и скорость прогрессирования заболевания. При проведении ТМС у всех участников исследования определялись: 1) пассивный моторный порог (МП); 2) средняя амплитуда вызванного моторного ответа (ВМО) при предъявлении 30 стимулов с интенсивностью 120 % от МП; 3) SICI с использованием алгоритма с оптимизированным параллельным отслеживанием порога с межстимульными интервалами (МИ) 1,0; 1,5; 2,0; 2,5; 3,0; 3,5; 4,0; 5,0; 7,0 мс, а также среднее торможение для измерений в диапазоне МИ от 1,0 до 3,0 мс и от 1,0 до 7,0 мс.</p><p><bold>Результаты</bold>. МП и амплитуда ВМО статистически значимо не различались между группами. При БАС было выявлено статистически значимое снижение SICI при МИ 1,0 и 2,0 мс, а также для усредненных значений с МИ от 1,0 до 3,0 мс. Статистически значимой корреляции МП, амплитуд ВМО и SICI с клиническими показателями не обнаружено.</p><p><bold>Выводы</bold>. В настоящем репликационном исследовании подтверждена возможность выявления при БАС нарушений внутрикоркового торможения при ТМС парными стимулами с применением методики отслеживания порога.</p></trans-abstract><kwd-group xml:lang="en"><kwd>transcranial magnetic stimulation</kwd><kwd>paired-pulse stimulation</kwd><kwd>intracortical inhibition</kwd><kwd>threshold tracking</kwd><kwd>amyotrophic lateral sclerosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>транскраниальная магнитная стимуляция</kwd><kwd>стимуляция парными стимулами</kwd><kwd>внутрикорковое торможение</kwd><kwd>«отслеживание порога»</kwd><kwd>боковой амиотрофический склероз</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Feldman E.L., Goutman S.A., Petri S. et al. Amyotrophic lateral sclerosis. Lancet 2022;400(10360):1363–80. DOI: 10.1016/S0140-6736(22)01272-7</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Corcia P., Lunetta C., Vourch P. et al. Time for optimism in amyotrophic lateral sclerosis. Eur J Neurol 2023;30(5):1459–64. DOI: 10.1111/ene.15738</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Saini A., Chawla P.A. Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis. Eur J Neurol 2024;31(2):e16140. DOI: 10.1111/ene.16140</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Brooks B.R., Miller R.G., Swash M. et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293–9. DOI: 10.1080/146608200300079536</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Shefner J.M., Al-Chalabi A., Baker M.R. et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 2020;131(8):1975–8. DOI: 10.1016/j.clinph.2020.04.005</mixed-citation></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Bakulin I.S., Zakroyshchikova I.V., Suponeva N.A., Zakharova M.N. Amyotrophic lateral sclerosis: Clinical heterogeneity and approaches to classification. Nervno-myshechnye bolezni = Neuromuscular Diseases 2017;7(3):10–20. (In Russ.). DOI: 10.17650/2222-8721-2017-7-3-10-20</mixed-citation><mixed-citation xml:lang="ru">Бакулин И.С., Закройщикова И.В., Супонева Н.А., Захарова М.Н. Боковой амиотрофический склероз: клиническая гетерогенность и подходы к классификации. Нервно-мышечные болезни 2017;7(3):10–20. DOI: 10.17650/2222-8721-2017-7-3-10-20</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><mixed-citation>Pinto W.B.V.R., Debona R., Nunes P.P. et al. Atypical motor neuron disease variants: Still a diagnostic challenge in Neurology. Rev Neurol (Paris) 2019;175(4):221–32. DOI: 10.1016/j.neurol.2018.04.016</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Kraemer M., Buerger M., Berlit P. Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2010;112(2):103–5. DOI: 10.1016/j.clineuro.2009.10.014</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Gwathmey K.G., Corcia P., McDermott C.J. et al. Diagnostic delay in amyotrophic lateral sclerosis. Eur J Neurol 2023;30(9):2595– 601. DOI: 10.1111/ene.15874 10. Timmins H.C., Vucic S., Kiernan M.C. Cortical hyperexcitability in amyotrophic lateral sclerosis: From pathogenesis to diagnosis. Curr Opin Neurol 2023;36(4):353–9. DOI: 10.1097/WCO.0000000000001162</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Vucic S., Stanley Chen K.H., Kiernan M.C. et al. Clinical diagnostic utility of transcranial magnetic stimulation in neurological disorders. Updated report of an IFCN committee. Clin Neurophysiol 2023;150:131–75. DOI: 10.1016/j.clinph.2023.03.010</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Vucic S., de Carvalho M., Bashford J., Alix J.J.P. Contribution of neurophysiology to the diagnosis and monitoring of ALS. Int Rev Neurobiol 2024;176:87–118. DOI: 10.1016/bs.irn.2024.04.001</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Crabé R., Aimond F., Gosset P. et al. How degeneration of cells surrounding motoneurons contributes to amyotrophic lateral sclerosis. Cells 2020;9(12):2550. DOI: 10.3390/cells9122550</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Vucic S., van den Bos M., Menon P. et al. Utility of threshold tracking transcranial magnetic stimulation in ALS. Clin Neurophysiol Pract 2018;3:164–72. DOI: 10.1016/j.cnp.2018.10.002</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Vucic S., Cheah B.C., Yiannikas C., Kiernan M.C. Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 2011;122(9):1860–6. DOI: 10.1016/j.clinph.2010.12.062</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Menon P., Geevasinga N., Yiannikas C. et al. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: A prospective study. Lancet Neurol 2015;14(5):478–84. DOI: 10.1016/S1474-4422(15)00014-9 17. Geevasinga N., Menon P., Yiannikas C. et al. Diagnostic utility of cortical excitability studies in amyotrophic lateral sclerosis. Eur J Neurol 2014;21(12):1451–7. DOI: 10.1111/ene.12422</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Geevasinga N., Howells J., Menon P. et al. Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS. Neurology 2019;92(6):e536–47. DOI: 10.1212/WNL.0000000000006876</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Tankisi H., Nielsen C.S., Howells J. et al. Early diagnosis of amyotrophic lateral sclerosis by threshold tracking and conventional transcranial magnetic stimulation. Eur J Neurol 2021;28(9):3030–9. DOI: 10.1111/ene.15010</mixed-citation></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Bakulin I.S., Zabirova A.H., Poydasheva A.G. et al. Reliability of intracortical inhibiton measured using threshold tracking technique. Nervno-myshechnye bolezni = Neuromuscular Diseases 2023;13(4):10–9. (In Russ.). DOI: 10.17650/2222-8721-2023-13-4-10-19</mixed-citation><mixed-citation xml:lang="ru">Бакулин И.С., Забирова А.Х., Пойдашева А.Г. и соавт. Надежность оценки внутрикоркового торможения с применением методики отслеживания порога. Нервно-мышечные болезни 2023;13(4):10–9. DOI: 10.17650/2222-8721-2023-13-4-10-19</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><mixed-citation>Roche J.C., Rojas-Garcia R., Scott K.M. et al. A proposed staging system for amyotrophic lateral sclerosis. Brain 2012;135(Pt 3):847–52. DOI: 10.1093/brain/awr351</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Groppa S., Oliviero A., Eisen A. et al. A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee. Clin Neurophysiol 2012;123(5):858–82. DOI: 10.1016/j.clinph.2012.01.010</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Higashihara M., Pavey N., Menon P. et al. Reduction in short interval intracortical inhibition from the early stage reflects the pathophysiology in amyotrophic lateral sclerosis: A meta-analysis study. Eur J Neurol 2024;31(7):e16281. DOI: 10.1111/ene.16281</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Nielsen C.S., Samusyte G., Pugdahl K. et al. Test-retest reliability of short-interval intracortical inhibition assessed by thresholdtracking and automated conventional techniques. eNeuro 2021;8(5):ENEURO.0103-21.2021. DOI: 10.1523/ENEURO.0103-21.2021</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Tankisi H., Cengiz B., Howells J. et al. Short-interval intracortical inhibition as a function of inter-stimulus interval: Three methods compared. Brain Stimul 2021;14(1):22–32. DOI: 10.1016/j.brs.2020.11.002</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Samusyte G., Bostock H., Rothwell J., Koltzenburg M. Shortinterval intracortical inhibition: Comparison between conventional and threshold-tracking techniques. Brain Stimul 2018;11(4):806–17. DOI: 10.1016/j.brs.2018.03.002</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>McMackin R., Tadjine Y., Fasano A. et al. Examining short interval intracortical inhibition with different transcranial magnetic stimulation-induced current directions in ALS. Clin Neurophysiol Pract 2024;9:120–9. DOI: 10.1016/j.cnp.2024.03.001</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Tankisi H., Pia H., Strunge K. et al. Three different short-interval intracortical inhibition methods in early diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2023;24(1-2):139–47. DOI: 10.1080/21678421.2022.2101926</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Menon P., Higashihara M., van den Bos M. et al. Cortical hyperexcitability evolves with disease progression in ALS. Ann Clin Transl Neurol 2020;7(5):733–41. DOI: 10.1002/acn3.51039</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Shibuya K., Park S.B., Geevasinga N. et al. Threshold tracking transcranial magnetic stimulation: Effects of age and gender on motor cortical function. Clin Neurophysiol 2016;127(6):2355–61. DOI: 10.1016/j.clinph.2016.03.009</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Peinemann A., Lehner C., Conrad B., Siebner H.R. Age-related decrease in paired-pulse intracortical inhibition in the human primary motor cortex. Neurosci Lett 2001;313(1–2):33–6. DOI: 10.1016/s0304-3940(01)02239-x</mixed-citation></ref></ref-list></back></article>
